维昇药业(上海)有限公司 Revenue and Competitors
Estimated Revenue & Valuation
- 维昇药业(上海)有限公司's estimated annual revenue is currently $9.6M per year.
- 维昇药业(上海)有限公司's estimated revenue per employee is $201,000
Employee Data
- 维昇药业(上海)有限公司 has 48 Employees.
- 维昇药业(上海)有限公司 grew their employee count by -19% last year.
维昇药业(上海)有限公司's People
Name | Title | Email/Phone |
---|
维昇药业(上海)有限公司 Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is 维昇药业(上海)有限公司?
维昇è¯ä¸šï¼ˆVISEN Pharma)致力æˆä¸ºå†…分泌相关治疗领域的专家,将全çƒé¢†å…ˆçš„治疗方法åŠè¯å“引入ä¸å›½ï¼ŒæœŸæœ›è®©æ›´å¤šçš„ä¸å›½æ‚£è€…更早地å—æƒ äºŽå…¨çƒå…ˆè¿›å¯é 的治疗方案。 维昇è¯ä¸šäºŽ2018å¹´æˆç«‹ï¼Œç”±Ascendis Pharma A/S (Nasdaq: ASND)与维梧资本(Vivo Capital)领导的è”åˆæŠ•èµ„人共åŒåˆ›ç«‹ï¼ŒSofinnova Ventureså‚与首轮投资。维昇获得Ascendis独家授æƒï¼Œå°†å…¶æ——下的内分泌治疗方案在大ä¸åŽåŒºå¼€å‘并推广,授æƒè¦†ç›–ä¸å›½å¤§é™†åŠæ¸¯æ¾³å°ç‰åœ°åŒºã€‚ Ascendis Pharma A/S (Nasdaq: ASND)始建于2006,总部ä½äºŽä¸¹éº¦å“¥æœ¬å“ˆæ ¹ï¼Œåœ¨å¾·å›½æµ·å¾·å°”å ¡å’Œç¾Žå›½åŠ å·žçš„å¸•æ´›é˜¿å°”æ‰˜è®¾æœ‰åŠžå…¬å®¤ï¼Œæ˜¯ä¸€å®¶æ‹¥æœ‰å…¨çƒç‹¬åˆ›é•¿æ•ˆæŠ€æœ¯å¹³å°çš„生物制è¯å…¬å¸ï¼Œè‡´åŠ›äºŽä¸ºæ‚£è€…带æ¥çœŸæ£ä¸ä¸€æ ·çš„生活。Ascendisåœ¨å…¶æ ¸å¿ƒä»·å€¼è§‚ “患者第一,科技领先,全情投入†指引下,利用TransConä¸“åˆ©æŠ€æœ¯ç ”å‘新型有效的最佳治疗方案。 维梧资本(VIVO Capital)æˆç«‹äºŽ1996年,是一家专注于生命科å¦å’Œå¥åº·åŒ»ç–—领域的投资公å¸ï¼Œç»´æ¢§èµ„æœ¬æ€»éƒ¨è®¾åœ¨ç¾Žå›½åŠ å·žçš„å¸•æ´›é˜¿å°”æ‰˜ï¼Œå¹¶åœ¨åŒ—äº¬ã€ä¸Šæµ·ã€é¦™æ¸¯å’Œå°åŒ—设有办公室。 维昇è¯ä¸šæ€»éƒ¨ä½äºŽä¸Šæµ·ï¼Œåœ¨ä¸å›½å¤§é™†çš„主è¦ä¸šåŠ¡ä¸å¿ƒä½äºŽåŒ—京ã€ä¸Šæµ·ã€‚
keywords:N/AN/A
Total Funding
48
Number of Employees
$9.6M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.8M | 52 | -10% | N/A |
#2 | $7.1M | 56 | -8% | N/A |
#3 | $14.9M | 60 | -10% | N/A |
#4 | $8M | 61 | -18% | N/A |
#5 | $14.9M | 93 | 58% | N/A |